{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:54:38Z","timestamp":1786366478687,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1067\/mhj.2002.124052","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T14:50:03Z","timestamp":1042123803000},"page":"359-364","source":"Crossref","is-referenced-by-count":32,"title":["Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas\/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy"],"prefix":"10.1067","volume":"144","author":[{"given":"Stamatis","family":"Adamopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Georgiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karatzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Paraskevaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kroupis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Karavolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Koniavitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios Th.","family":"Kremastinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.124052_bib1","doi-asserted-by":"crossref","unstructured":"Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897-904.","DOI":"10.1378\/chest.105.3.897"},{"key":"10.1067\/mhj.2002.124052_bib2","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(97)00055-7","article-title":"Plasma Fas Ligand, an inducer of apoptosis, and plasma soluble Fas an inhibitor of apoptosis, in patients with chronic congestive heart failure","volume":"29","author":"Nishigaki","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib4","first-page":"R577","article-title":"Tumor necrosis factor in the heart","volume":"274","author":"Meldrum","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1067\/mhj.2002.124052_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0008-6363(99)00050-4","article-title":"New insights into the pathophysiological role for cytokines in heart failure","volume":"42","author":"Sasayama","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"A Suppl","key":"10.1067\/mhj.2002.124052_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0735-1097(98)82076-7","article-title":"Clinical correlates and prognostic value of apoptosis mediator soluble forms in patients with congestive heart failure [abstract]","volume":"32","author":"Parissis","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib7","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0002-9149(97)00228-2","article-title":"Serum levels of soluble form Fas molecule in patients with congestive heart failure","volume":"79","author":"Okuyama","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.CIR.92.2.262","article-title":"Growth hormone improves cardiac performance in experimental heart failure","volume":"92","author":"Yang","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.124052_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/01.CIR.100.19.2003","article-title":"Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure","volume":"100","author":"Houck","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.124052_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/00003495-200060040-00002","article-title":"Role of growth hormone in chronic heart failure: therapeutic implications","volume":"60","author":"Volterani","year":"2000","journal-title":"Drugs"},{"key":"10.1067\/mhj.2002.124052_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM199603283341301","article-title":"A preliminary study of growth hormone in the treatment of dilated cardiomyopathy","volume":"334","author":"Fazio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.124052_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/oxfordjournals.eurheartj.a060067","article-title":"The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic heart failure","volume":"13","author":"Riley","year":"1992","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.124052_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1979.tb05903.x","article-title":"The two-period cross-over clinical trial","volume":"8","author":"Hills","year":"1979","journal-title":"Br J Clin Pharmacol"},{"issue":"B Suppl","key":"10.1067\/mhj.2002.124052_bib14","first-page":"2","article-title":"Oxidative stress during myocardial ischemia and heart failure","volume":"19","author":"Ferrari","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.124052_bib15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.92.6.1479","article-title":"Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure","volume":"92","author":"Ferrari","year":"1995","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.124052_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","article-title":"Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension","volume":"28","author":"Testa","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1253\/jcj.62.873","article-title":"Increased circulating soluble form of Fas in patients with dilated cardiomyopathy","volume":"62","author":"Kawakami","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1067\/mhj.2002.124052_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0002-9149(99)00133-2","article-title":"Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure","volume":"83","author":"Yamaguchi","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0735-1097(99)00495-7","article-title":"Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure","volume":"34","author":"Gullestad","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0735-1097(97)00145-9","article-title":"Role of cytokines in the mechanism of action of amlodipine: the PRAISE heart failure trial","volume":"30","author":"Mohler","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1388-9842(00)00080-5","article-title":"Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT","volume":"2","author":"Thackray","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1067\/mhj.2002.124052_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-8703(00)90224-2","article-title":"Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines","volume":"139","author":"de Vries","year":"2000","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.124052_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(00)01121-9","article-title":"Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy","volume":"37","author":"Ohtsuka","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/euhj.2000.2285","article-title":"Physical training reduces peripheral markers of inflammation in patients with chronic heart failure","volume":"22","author":"Adamopoulos","year":"2001","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"10.1067\/mhj.2002.124052_bib25","first-page":"522","article-title":"Effects of physical training on soluble apoptosis mediators and circulating proinflammatory cytokines in chronic heart failure [abstract]","volume":"102","author":"Adamopoulos","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.124052_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s003950070018","article-title":"Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy","volume":"95","author":"Hongo","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1067\/mhj.2002.124052_bib27","first-page":"183","article-title":"Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study","volume":"51","author":"Josc","year":"1999","journal-title":"Indian Heart J"},{"key":"10.1067\/mhj.2002.124052_bib28","first-page":"242","article-title":"Why growth hormone therapy is efficient in heart failure","volume":"20","author":"Beranek","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1067\/mhj.2002.124052_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/oxfordjournals.eurheartj.a015237","article-title":"Growth hormone and heart performance: a novel mechanism of cardiac wall stress regulation in humans","volume":"18","author":"Fazio","year":"1997","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T19:21:21Z","timestamp":1554924081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0002870302000923"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.124052","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}